Top Markets
Coin of the day
EyePoint Pharmaceuticals, Inc. EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc.

EYPT
Xếp hạng trong cổ phiếu #15062
EyePoint Pharmaceuticals, Inc. is a pharmaceutical firm dedicated to the... EyePoint Pharmaceuticals, Inc. is a pharmaceutical firm dedicated to the creation and marketing of ophthalmic solutions for various eye ailments. Its operations span the United States, China, and the United Kingdom. Among its commercialized product portfolio are ILUVIEN, an injectable, sustained-release micro-insert designed to treat diabetic macular edema, and YUTIQ, an intravitreal implant containing fluocinolone acetonide, which targets chronic non-infectious uveitis impacting the posterior segment of the eye. The company also offers DEXYCU, a dexamethasone intraocular suspension, utilized to manage post-operative ocular inflammation, such as that occurring after cataract surgery. Looking ahead, EyePoint is actively developing several pipeline therapies. This includes EYP-1901, a novel, bioerodible tyrosine kinase inhibitor currently formulated for twice-yearly administration, which is under development for conditions like wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. Additionally, YUTIQ50 is being advanced as a treatment for chronic non-infectious uveitis affecting the posterior region of the eye. To bolster its market reach and development efforts, the company maintains strategic alliances with entities such as Alimera Sciences, Inc., Bausch & Lomb, OncoSil Medical UK Limited, Ocumension Therapeutics, and Equinox Science, LLC. Furthermore, a commercial collaboration with ImprimisRx PA, Inc. specifically focuses on the joint promotion of DEXYCU for inflammation following ocular surgery. Incorporated in 1987, the organization was previously known as pSivida Corp. before officially rebranding as EyePoint Pharmaceuticals, Inc. in March 2018. Its corporate headquarters are situated in Watertown, Massachusetts.
Giá cổ phiếu
$4.48
Đồng bộ lần cuối: 2026-08-31
Vốn hóa thị trường
$375.37M
Thay đổi (1 ngày)
-0.06%
Thay đổi (1 năm)
-61.30%
Quốc gia
US
Giao dịch EyePoint Pharmaceuticals, Inc. (EYPT)

Danh mục

Lịch sử giá cổ phiếu của EyePoint Pharmaceuticals, Inc. (EYPT)
Giá đóng cửa cao nhất: $8.36 vào 2026-08-01

Giá đóng cửa thấp nhất: $379.87 vào 2005-01-01
Lịch sử giá cổ phiếu của EyePoint Pharmaceuticals, Inc. từ 2005 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -19.87%
2025 116.50%
2024 -60.60%
2023 566.15%
2022 -78.68%
2021 183.07%
2020 -66.89%
2019 -27.25%
2018 80.00%
2017 -34.90%
2016 -56.63%
2015 -4.94%
2014 30.94%
2013 151.21%
2012 5.04%
2011 -78.05%
2010 47.76%
2009 269.05%
2008 -68.77%
2007 -56.96%
2006 -61.72%
2005 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$747.04 4.70%
CH